You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,821,920


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,821,920 protect, and when does it expire?

Patent 8,821,920 protects QUTENZA and is included in one NDA.

This patent has thirty-two patent family members in twenty-three countries.

Summary for Patent: 8,821,920
Title:Therapeutic patch for transdermal delivery of capsaicin
Abstract: The invention relates to a topical patch comprising a therapeutic compound-impermeable backing layer, a self-adhesive matrix based on polysiloxanes and containing capsaicin or a therapeutic compound analogous to capsaicin, and a protective film to be removed before use, in which the matrix contains liquid microreservoirs based on an amphiphilic solvent, in which the therapeutic compound is present in completely dissolved form and the concentration of the therapeutic compound in the microreservoir droplets is below the saturation concentration. The invention furthermore relates to a process for its production and its use in the treatment of neuropathic pain.
Inventor(s): Muller; Walter (Andernach, DE)
Assignee: LTS Lohmann Therapie Systeme AG (Andernach, DE)
Application Number:10/823,119
Patent Claim Types:
see list of patent claims
Use; Formulation; Compound;
Patent landscape, scope, and claims:

United States Patent 8,821,920 B2: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

The United States Patent 8,821,920 B2, titled "Therapeutic patch for transdermal delivery of capsaicin," is a significant invention in the field of pharmaceuticals and medical devices. This patent, granted to its inventors, outlines a novel method and device for the transdermal delivery of capsaicin, a compound used to treat neuropathic pain. Here, we will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Patent Overview

Invention Description

The patent describes a therapeutic patch designed for the transdermal delivery of capsaicin or capsaicin analogs. The patch consists of several key components:

  • A therapeutic compound-impermeable backing layer.
  • A self-adhesive matrix based on polysiloxanes, containing microreservoir droplets with capsaicin or its analogs dissolved in an amphiphilic solvent.
  • A protective film to be removed before use[4][5].

Purpose and Application

The primary purpose of this invention is to provide an effective method for treating neuropathic pain. The patch is designed to deliver capsaicin, which is known for its analgesic properties, directly through the skin, avoiding the need for oral administration and its associated side effects.

Scope of the Patent

Claim Structure

The patent includes multiple claims that define the scope of the invention. These claims can be categorized into several types:

  • Independent Claims: These define the broadest aspects of the invention, such as the composition of the patch and its method of use.
  • Dependent Claims: These narrow down the invention by specifying particular details, such as the concentration of capsaicin in the microreservoirs or the type of polymers used in the self-adhesive matrix[4].

Claim Metrics

Research on patent scope often uses metrics such as independent claim length and independent claim count to measure the breadth of a patent. For this patent, the claims are structured to ensure clarity and specificity, which is crucial for maintaining patent quality and avoiding overly broad claims that could lead to litigation[3].

Claims Analysis

Key Claims

  • Claim 1: Describes the therapeutic patch comprising a backing layer, a self-adhesive matrix with microreservoir droplets containing capsaicin, and a protective film.
  • Claim 2: Specifies the concentration of capsaicin in the microreservoirs and the type of solvent used.
  • Claim 3: Outlines the method of treating neuropathic pain using the patch[4].

Claim Validity and Scope

The validity and scope of these claims are critical. Narrower claims, as seen in this patent, are often associated with a higher probability of grant and a shorter examination process. This suggests that the inventors have carefully crafted the claims to ensure they are specific and enforceable[3].

Patent Landscape

Prior Art and Citations

The patent cites several prior art documents related to transdermal drug delivery systems and the use of capsaicin for pain relief. The Common Citation Document (CCD) application, which consolidates prior art cited by multiple patent offices, would be useful in understanding the global context of this invention[1].

International Patent Offices

To assess the global patent landscape, one would need to search databases from other international intellectual property offices such as the European Patent Office (EPO), Japan Patent Office (JPO), and the World Intellectual Property Organization (WIPO)[1].

Competing Patents

A thorough search using resources like the USPTO's Patent Public Search tool, Global Dossier, and other international databases would reveal competing patents in the field of transdermal drug delivery. This analysis helps in understanding the competitive environment and potential infringement risks[1].

Search and Examination Process

USPTO Resources

The USPTO provides several resources for conducting thorough patent searches, including the Patent Public Search tool, which replaced legacy tools like PubEast and PubWest. The Global Dossier service is also invaluable for accessing file histories of related applications from participating IP offices[1].

Examination Data

The Patent Examination Data System (PEDS) allows users to search, view, and download bibliographic data for publicly available patent applications. This can provide insights into the examination process and any office actions related to this patent[1].

Practical Implications

Commercial Use

The therapeutic patch described in this patent has significant commercial potential, especially in the treatment of neuropathic pain. The self-adhesive matrix and microreservoir system ensure a controlled release of capsaicin, making it a viable alternative to traditional pain relief methods.

Regulatory Compliance

To bring this product to market, the inventors must comply with regulatory requirements. This includes obtaining necessary approvals from health authorities and ensuring that the manufacturing process adheres to quality and safety standards.

Key Takeaways

  • Invention Specificity: The patent is specific about the composition and method of use of the therapeutic patch.
  • Claim Structure: The claims are well-structured to ensure clarity and enforceability.
  • Global Context: Understanding the global patent landscape is crucial for assessing competition and potential infringement risks.
  • Regulatory Compliance: Compliance with health and safety regulations is essential for commercialization.

FAQs

Q: What is the primary purpose of the therapeutic patch described in US Patent 8,821,920 B2?

A: The primary purpose is to treat neuropathic pain through the transdermal delivery of capsaicin.

Q: What are the key components of the therapeutic patch?

A: The patch consists of a therapeutic compound-impermeable backing layer, a self-adhesive matrix with microreservoir droplets containing capsaicin, and a protective film.

Q: How do the claims in this patent contribute to its validity and scope?

A: The claims are structured to be specific and narrow, which is associated with a higher probability of grant and a shorter examination process.

Q: What resources can be used to conduct a thorough patent search related to this invention?

A: Resources include the USPTO's Patent Public Search tool, Global Dossier, and databases from other international intellectual property offices.

Q: Why is regulatory compliance important for this invention?

A: Regulatory compliance is essential to ensure the product meets health and safety standards and to obtain necessary approvals for commercial use.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. USA.gov - U.S. Patent and Trademark Office (USPTO): https://www.usa.gov/agencies/u-s-patent-and-trademark-office
  3. SSRN - Patent Claims and Patent Scope: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. Google Patents - Therapeutic patch for transdermal delivery of capsaicin: https://patents.google.com/patent/US8821920B2/en
  5. US Patent Document - Therapeutic patch for transdermal delivery of capsaicin: https://patentimages.storage.googleapis.com/73/61/c2/5615f1c7b99aaa/US8821920.pdf

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,821,920

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Averitas QUTENZA capsaicin PATCH;TOPICAL 022395-001 Nov 16, 2009 RX Yes Yes ⤷  Subscribe ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.